Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials

Head and Neck

Volumn 38, Issue , 2016, Pages E1863-E1869

  Mehanna, Hisham ^a   Franklin, Natalie ^b   Compton, Natalie ^c   Robinson, Max ^d   Powell, Ned ^e   Biswas Baldwin, Nigel ^f   Paleri, Vindh ^g   Hartley, Andrew ^h   Fresco, Lydia ⁱ   Al Booz, Hoda ^j   Junor, Elizabeth ^k   El Hariry, Iman ^l   Roberts, Sally ^a   Harrington, Kevin ^m   Ang, K Kian ⁿ   Dunn, Janet ^o   Woodman, Ciaran ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROCHE PRODUCTS LTD   (United Kingdom)

^c PPD Development   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f GLAXOSMITHKLINE   (United Kingdom)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^j BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^k WESTERN GENERAL HOSPITAL   (United Kingdom)

^l Synta Pharmaceuticals Corp   (United States)

^m INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o UNIVERSITY OF WARWICK   (United Kingdom)

more..

Author keywords

head and neck cancer; human papillomavirus; oropharynx; prevalence; squamous cell carcinoma

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEIN P16; VIRUS DNA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; P16 PROTEIN, HUMAN;

ADULT; ASIA; CLINICAL PROTOCOL; CONFERENCE PAPER; EASTERN EUROPE; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SMOKING; TISSUE MICROARRAY; TISSUE SECTION; WART VIRUS; WESTERN EUROPE; COMPLICATION; EUROPE; GENETICS; GEOGRAPHY; OROPHARYNX TUMOR; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; EUROPE; GEOGRAPHY; HUMANS; IMMUNOHISTOCHEMISTRY; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84954096312     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24336     Document Type: Conference Paper

References (20)

1. Mehanna H, Beech T, Nicholson T, et al., Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013; 35: 747-755.
2. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
3. Mehanna H, Jones TM, Gregoire V, Ang KK,. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010; 340: c1439.
4. Kim JJ, Goldie SJ,. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009; 339: b3884.
5. Sturgis EM, Dahlstrom KR,. HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. BMJ 2009; 339: b4525.
6. D'Souza G, Kreimer AR, Viscidi R, et al., Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
7. Lajer CB, von Buchwald C,. The role of human papillomavirus in head and neck cancer. APMIS 2010; 118: 510-519.
8. Termine N, Panzarella V, Falaschini S, et al., HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008; 19: 1681-1690.
9. Smeets SJ, Hesselink AT, Speel EJ, et al., A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472.
10. Thavaraj S, Stokes A, Guerra E, et al., Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011; 64: 308-312.
11. Štulhofer A, Sandfort T, eds. Sexuality and gender in postcommunist Eastern Europe and Russia. Abingdon, Oxon, UK: The Haworth Press; 2005.
12. D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML,. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-1269.
13. Smith JS, Melendy A, Rana RK, Pimenta JM,. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008; 43 (4 Suppl): S5-S25.
14. Nunobiki O, Ueda M, Toji E, et al., Genetic polymorphism of cancer susceptibility genes and HPV infection in cervical carcinogenesis. Patholog Res Int 2011; 2011: 364069.
15. Wang SS, Gonzalez P, Yu K, et al., Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 2010; 5: e8667.
16. Hoffmann M, Quabius ES, Tribius S, et al., Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor. Oncol Rep 2013; 29: 1962-1968.
17. Fisher M,. Who smokes most: a surprising map of smoking rates by country. Washington Post, October 19, 2012. Available at: https://www.washingtonpost.com/blogs/worldviews/wp/2012/10/19/who-smokes-most-a-surprising-map-of-smoking-rates-by-country. Accessed February 1, 2015.
18. Evans M, Newcombe R, Fiander A, et al., Human papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population. BMC Cancer 2013; 13: 220.
19. Scapoli L, Palmieri A, Rubini C, et al., Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Modern Pathol 2009; 22: 366-372.
20. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM,. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-795.